HMB-45 is a marker of melanocyte differentiation that is less sensitive, but more specific, than S100 for the diagnosis of primary cutaneous melanoma [15], with various studies reporting 56.3 to 77% of melanomas as being HMB-45-positive [11,63,64,65]. Here, PMEL is linked to melanoma.